Research ArticleRESEARCH
Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber and Jos H. Beijnen
PDA Journal of Pharmaceutical Science and Technology September 2005, 59 (5) 285-297;
Monique W. J. Den Brok
Bastiaan Nuijen
J. Jantina Kettenes-Van Den Bosch
M. J. Van Steenbergen
Josie N. Buluran
Michael D. Harvey
Charles K. Grieshaber
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 59, Issue 5
September/October 2005
Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber, Jos H. Beijnen
PDA Journal of Pharmaceutical Science and Technology Sep 2005, 59 (5) 285-297;
Pharmaceutical Development of a Parenteral Lyophilised Dosage Form for the Novel Anticancer Agent C1311
Monique W. J. Den Brok, Bastiaan Nuijen, J. Jantina Kettenes-Van Den Bosch, M. J. Van Steenbergen, Josie N. Buluran, Michael D. Harvey, Charles K. Grieshaber, Jos H. Beijnen
PDA Journal of Pharmaceutical Science and Technology Sep 2005, 59 (5) 285-297;
Jump to section
Related Articles
- No related articles found.